Accessibility Menu
BioVie logo

BioVie

(NASDAQ) BIVI

Current Price$2.25
Market Cap$17.12MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2014)-100%
5 Year-100%
1 Year-70%
1 Month+39%

BioVie Financials at a Glance

Market Cap

$17.12MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$19.92M

EPS (TTM)

-$4.27

P/E Ratio

-0.53

Dividend

$0.00

Beta (Volatility)

1.48 (Average)

Price

$2.25

Volume

172,597.556

Open

$2.30

Previous Close

$2.27

Daily Range

$2.08 - $2.31

52-Week Range

$1.06 - $9.09

Estimated Earnings Date

Sep 2, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BioVie

Industry

Biotechnology

Employees

13

CEO

Cuong Viet Do, MBA

Headquarters

Carson City, NV 89703, US

BIVI Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-101.09%

Return on Capital

-93.31%

Return on Assets

-113.71%

Earnings Yield

-1.89%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$17.12MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

7.54M

Volume

172.60K

Avg. Volume

132.70K

Financials (TTM)

Gross Profit

-$229.38K

Operating Income

-$20.60M

EBITDA

-$19.71M

Operating Cash Flow

-$20.51M

Capital Expenditure

$0.00

Free Cash Flow

-$20.51M

Cash & ST Invst.

$13.10M

Total Debt

$295.72K

BioVie Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$57.34K

N/A

Gross Margin

0.00%

N/A

Market Cap

$17.12MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.22M

N/A

Employees

14

N/A

Net Income

-$5.27M

-89.0%

EBITDA

-$5.21M

-91.0%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Total Cash

$13.10M

-43.4%

Total Debt

$295.72K

-19.3%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$213.32K

-27.9%

Short Term Debt

$82.40K

+16.5%

Return on Assets

-1.14%

N/A

Return on Invested Capital

-1.30%

N/A

Free Cash Flow

-$7.44M

-493.7%

Operating Cash Flow

-$7.44M

-493.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
KZIAKazia Therapeutics Ltd ADR
$13.56+4.47%
GLMDGalmed Pharmaceuticals Ltd.
$0.56-1.75%
INMInMed Pharmaceuticals Inc.
$1.64-1.20%
ARTLArtelo Biosciences, Inc.
$1.08+5.88%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOFISoFi Technologies
$18.78+0.01%
PATHUiPath
$11.68-0.01%
FRMIFermi
$6.59-0.10%
ONDSOndas
$7.26-0.05%

Questions About BIVI

What is the current price of BioVie?

BioVie is trading at $2.27 per share.

What is the 52-week range for BioVie?

Over the past 52 weeks, BioVie has traded between $1.06 and $9.09.

How much debt does BioVie have?

As of the most recent reporting period, BioVie reported total debt of $295.72K.

How much cash does BioVie have on hand?

BioVie reported $13.10M in cash and cash equivalents in its most recent financial results.

What is BioVie’s dividend yield?

BioVie does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.